45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,512
Insurances with rates
5
CPT / HCPCS codes
4,012
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 702072 | HD-ANDEXXA IV PWD FOR SOLN 200MG | $33,581 | $25,186 | — | — | 3 |
| 701952 | SKYRIZI INTRAVENOUS SOLUTION 600MG/1 | $23,750 | $17,813 | — | — | 3 |
| 702176 | NF-Ninlaro Oral Capsule 4MG | $13,575 | $10,181 | — | — | 3 |
| 78965 | RETEPLASE (RETAVASE) : 20 UNIT KIT | $13,247 | $9,935 | — | — | 3 |
| 73435 | ALTEPLASE (ACTIVASE) 1MG/ML | $13,055 | $9,792 | — | — | 3 |
| 74970 | PEGFILGRASTIM (NEULASTA)SYR : 6MG/0. | $10,093 | $7,570 | — | — | 3 |
| 701873 | SYNAGIS INTRAMUSCULAR SOLUTION 100MG | $8,225 | $6,169 | — | — | 3 |
| 701993 | GAMMAGARD LIQUID 30G | $8,135 | $6,101 | — | — | 3 |
| 702144 | ACTIVASE IV POWDER FOR SOLUTION 50MG | $6,528 | $4,896 | — | — | 3 |
| 73609 | DIGOXIN IMMUNE FAB (DIGIFAB) 40MG/4M | $6,455 | $4,841 | — | — | 3 |
| 13725 | MYELOID NGS PANEL | $6,150 | $4,613 | — | — | 3 |
| 12438 | CYSTIC FIBROSIS GENE SEQUENCE #10917 | $6,000 | $4,500 | — | — | 3 |
| 701832 | MONOFERRIC 1000MG | $5,855 | $4,391 | — | — | 3 |
| 13748 | LYNCH SYNDROME PANEL # 91461 | $5,672 | $4,254 | — | — | 3 |
| 13787 | LYNCH SYNDROME PANEL | $5,672 | $4,254 | — | — | 3 |
| 13704 | BRCAVANTAGE COMP #91863 | $5,537 | $4,152 | — | — | 3 |
| 701935 | NF-ENBREL SUBCUTANEOUS SOLUTION 50MG | $5,287 | $3,965 | — | — | 3 |
| 701936 | NF-Enbrel Subcutaneous Solution 50MG | $5,287 | $3,965 | — | — | 3 |
| 13692 | CHROMOSOMAL MICROARRAY SNP | $5,150 | $3,863 | — | — | 3 |
| 72659 | FORTEO INJECTION | $4,917 | $3,688 | — | — | 3 |
| 700532 | ARANESP 300MCG/0.6ML INJECTION | $4,500 | $3,375 | — | — | 3 |
| 701653 | NF-Enbrel Mini Subcutaneous Soln 50M | $4,167 | $3,125 | — | — | 3 |
| 600015 | O.R. SERVICES - LAPRASCOPE II | $4,052 | $3,039 | — | — | 3 |
| 701846 | EVENITY | $3,943 | $2,957 | — | — | 3 |
| 76499 | RABIES IMMUNE GLOBULIN (HYPERRAB) | $3,850 | $2,888 | — | — | 3 |
| 700693 | NF-HUMIRA SUBCUTANEOUS SOLUTION 40MG | $3,754 | $2,815 | — | — | 3 |
| 702071 | LD-ANDEXXA IV PWD FOR SOLN 200MG | $3,731 | $2,798 | — | — | 3 |
| 701467 | NF-ENBREL MINI SUBCUTANEOUS SOLN 50M | $3,729 | $2,796 | — | — | 3 |
| 13721 | PRENATAL CARRIER PANEL #93349 | $3,358 | $2,519 | — | — | 3 |
| 40121 | CT ABD/PEL W/W-O CONTRAST | $3,351 | $2,513 | — | — | 3 |
| 12554 | PHENOSENSE #10421 | $3,306 | $2,480 | — | — | 3 |
| 702113 | NF-Pomalyst Oral Capsule 4MG | $3,276 | $2,457 | — | — | 3 |
| 702143 | LUPRON DEPOT IM 1 MONTH PWD FOR SUSP | $3,184 | $2,388 | — | — | 3 |
| 701119 | NF-ENBREL SUBCUTANEOUS SOLUTION 50MG | $3,136 | $2,352 | — | — | 3 |
| 701126 | NF-ENBREL SUBCUTANEOUS SOLUTION 50MG | $3,136 | $2,352 | — | — | 3 |
| 702000 | NF-Pomalyst Oral Capsule 4MG | $3,091 | $2,318 | — | — | 3 |
| 79484 | ANTIVENIN CROTALIDAE POLYVLNT( | $2,907 | $2,180 | — | — | 3 |
| 702104 | DUPIXENT 300MG/2ML PFS SUBQ SOLUTIO | $2,821 | $2,116 | — | — | 3 |
| 701518 | PROLIA SUBQ SOLN 60MG/1ML | $2,782 | $2,087 | — | — | 3 |
| 40120 | CT ABD AND PELVIS W/CONTRAST | $2,675 | $2,006 | — | — | 3 |
| 608150 | REMOVAL OF TOE | $2,636 | $1,977 | — | — | 3 |
| 608124 | PARTIAL REMOVAL OF TOE | $2,564 | $1,923 | — | — | 3 |
| 700207 | INFLIXIMAB (REMICADE) INJECTION | $2,484 | $1,863 | — | — | 3 |
| 76235 | AREDIA 90MG INJ | $2,404 | $1,803 | — | — | 3 |
| 608500 | BIOPSY / REMOVAL LYMPH NODES | $2,383 | $1,787 | — | — | 3 |
| 701328 | CROFAB IV PWD FOR SOLN | $2,372 | $1,779 | — | — | 3 |
| 252511 | CIRCUMCISION | $2,128 | $1,596 | — | — | 3 |
| 40192 | CTA CHEST PE W/WO CONTRAST | $2,122 | $1,591 | — | — | 3 |
| 41287 | CTA CHEST PE W/ CONTRAST | $2,122 | $1,591 | — | — | 3 |
| 41289 | CTA CHEST | $2,122 | $1,591 | — | — | 3 |
Showing top 50 of 6,512 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.